- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05859451
Effect of Tobacco Heating System (THS) on Closed Tibia Fracture Healing
November 28, 2023 updated by: Prof. Dr. rer. nat. Andreas Nüssler, University Hospital Tuebingen
Evaluation of Tobacco Heating System (THS) Compared to Conventional Cigarette Smoking During the Closed Tibia Fracture Healing in Orthopedic Smokers' Patients
The goal of this clinical trial is to investigate the role of switching from cigarette smoking (CS) to tobacco heat system (THS) on the clinical outcome of closed tibia fractures from smokers' orthopedic patients.
Validated and standardized assays, medical state and self-reported outcomes will be evaluated in orthopedic patients' smokers or switch from CS to using THS throughout six months compare to ex-smokers (control).
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Andreas K. Nüssler, Prof. Dr.
- Phone Number: +49070716061065
- Email: andreas.nuessler@med.uni-tuebingen.de
Study Contact Backup
- Name: Benedikt J. Braun, PD. Dr.
- Phone Number: +49070716063017
- Email: bbraun@bgu-tuebingen.de
Study Locations
-
-
Baden-Württemberg
-
Tübingen, Baden-Württemberg, Germany, 72076
- Recruiting
- Siegfried Weller Institutes, BG-Trauma Clinic, Department of Traumatology, Eberhard Karls University Tübingen
-
Contact:
- Andreas K. Nüssler, Prof. Dr.
- Phone Number: +49070716061065
- Email: andreas.nuessler@med.uni-tuebingen.de
-
Contact:
- Benedik J. Braun, PD. Dr. med.
- Phone Number: +49070716063017
- Email: bbraun@bgu-tuebingen.de
-
Principal Investigator:
- Andreas K. Nüssler, Prof. Dr.
-
Sub-Investigator:
- Benedik J. Braun, PD. Dr. med.
-
Sub-Investigator:
- Romina H. Aspera-Werz, Dr. sc. hum.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Closed tibial fracture (according to AO/OTA classification: 41A2-41C3, 42A-C, 43A-C) which is surgically treated within 14 days after the trauma at the BG trauma clinic Tübingen.
Additional inclusion criteria for the smoking and THS groups:
- Smokers with 10-20 packyears smoking history.
- Smoking history >10 years.
- Decision not to participate in the free smoking cessation seminars.
Exclusion Criteria:
- Legal guardian or loss of capacity to consent.
- Refusal to participate in the study.
- Open tibial fractures or concomitant injuries or complications requiring surgery existing at the time of surgical indication.
- Initial surgical treatment of the tibial fracture has occurred ex domo.
- No initial surgical treatment within 14 days of sustained trauma.
- Using nicotine delivery electronic devices.
- Pre-existing autoimmune, immunological, bone or malignant diseases.
- Pregnant, breastfeeding and women of childbearing age with existing desire to have children.
- History of alcohol abuse or drug abuse.
- Taking antioxidants approval by the German Federal Institute for Drugs and Medical Devices (BfArM).
- Taking drugs with known effect on bone metabolism (according to Institute for medical and pharmaceutical examination issues (IMPP): allosteric CaSR modulators, bisphosphonates, calcium release inhibitors, alkaline earth ions, RANKL inhibitors, calcitriol, colecalciferol).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Smokers
Participants subject to an orthopedic surgery (does not want to quit smoking conventional cigarettes) will continue smoking conventional cigarettes ad libitum for a period of 6 month post surgery
|
|
Experimental: Smokers willing to switch to THS
Participants subject to an orthopedic surgery (currently smoking conventional cigarettes) will start to used THS ad libitum for a period of 6 month post surgery
|
Participant who are not willing to quit cigarette smoking during the study duration will switch from cigarettes to using THS
Other Names:
|
Active Comparator: Ex Smokers
Participants subject to an orthopedic surgery will not smoke cigarettes or use electronic nicotine deliver systems for a period of 6 month post surgery
|
Participant who are willing to quit cigarette smoking and will not use any electronic nicotine delivery system during the study duration
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Concentration of Procollagen Type 1 N-Terminal Propeptide (CICP)
Time Frame: 6 months after tibia fracture surgery
|
Marker collagen formation - bone formation
|
6 months after tibia fracture surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Concentration of Alkaline Phosphatase (BAP)
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
Marker osteoblast activity
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
Concentration of Osteoprogesterin
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
Decoy receptor RANKL - inhibit osteoclast differentiation
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
Concentration of Osteopontin
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
Extracellular structural protein and an organic component of bone - favors osteoclast adherence
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
Concentration of N-terminal telopeptide (NTx)
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
Marker collagen degradation - bone resorption
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
Concentration of Interleukin 1 beta (IL-1β)
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Concentration of Interleukin 6 (IL-6)
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Concentration of Interferon gamma (IFN-γ)
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Concentration of Tumor Necrosis Factor Alpha (TNF-α)
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Number of bridged cortices in conventional X-ray
Time Frame: 6 months after tibia fracture surgery
|
6 months after tibia fracture surgery
|
|
Number of bridged cortices in computed tomography scan
Time Frame: 6 months after tibia fracture surgery
|
6 months after tibia fracture surgery
|
|
Bone Stiffness by a CT-based finite element method
Time Frame: 6 months after tibia fracture surgery
|
Finite element method will be used to simulate the mechanical behavior (linear-elastic range) of the tibia and predict bending stiffness under a 3-point bending test
|
6 months after tibia fracture surgery
|
Functional index in trauma (FIX-IT) - Score
Time Frame: 6 months after tibia fracture surgery
|
Assess weight-bearing and pain in patients with lower extremity fractures eight-bearing and pain in patients with lower extremity fractures.
The score rank from 0 to 12 points in 2 domains: the ability to bear weight (maximum 6 points) and pain at the fracture site (maximum 6 points).
The scores in both domains, which are weighted equally, are summed to obtain the final total score; (maximum 12 points indicates the highest level of function).
|
6 months after tibia fracture surgery
|
Loading of the injured extremity
Time Frame: 6 months after tibia fracture surgery
|
The time period with no, sole contact, partial or full load on the injured extremity.
|
6 months after tibia fracture surgery
|
Lower Extremity Functional Scale (LEFS) - Score
Time Frame: 6 months after tibia fracture surgery
|
The Lower Extremity Functional Scale (LEFS) is a questionnaire (20 questions) about a person's ability to perform everyday tasks.
The LEFS will be used to evaluate the functional impairment of a patient with a disorder of lower extremity.
The score rank from 0 to 80 points.
The maximum score (80 point) indicates no functional limitations.
|
6 months after tibia fracture surgery
|
Number of complications associated with the healing process
Time Frame: 6 months after tibia fracture surgery
|
6 months after tibia fracture surgery
|
|
Number of hospital stay and incapacity to work [days]
Time Frame: 6 months after tibia fracture surgery
|
6 months after tibia fracture surgery
|
|
Physicians Global Assessment to measure quality of life (PROMIS GH10 v 1.2) - Score
Time Frame: 6 months after tibia fracture surgery
|
The Global Health Patient-Reported Outcomes Measurement Information System (PROMIS- 10) scale is a ten-item patient reported measure of physical, mental and social health.
Two summary scores are calculated from the results of the questions: a global physical health score and a global mental health score.
These scores are then normalized to the general population using the "T-score."
The score ranges from 0 to 20 points.
0 points represent the most severe physical and/or mental impairment of the patient, while 20 points represent the best possible health status.
|
6 months after tibia fracture surgery
|
Visual Analog Score for pain (VAS) - Score
Time Frame: 6 months after tibia fracture surgery
|
Visual Analog Scale for Pain (VAS) provide an estimate of patients' pain intensity.
Scale from cero (no pain) to 10 (extreme pain).
|
6 months after tibia fracture surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Concentration of Soluble intercellular adhesion molecule-1 (sICAM-1)
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Concentration of High densitiy lipoprotein cholesterol levels (HDL)
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Concentration of Leucocytes
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Concentration of Erythrocytes
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Concentration of Hemoglobin
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Concentration of Thrombocytes
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Mean corpuscular volume
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Hematocrit levels
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Mean corpuscular hemoglobin levels
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Corpuscular hemoglobin concentration
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Protein c reactive levels
Time Frame: 6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
6 months after tibia fracture surgery (time points: approx. one week pre-, six weeks post-, twelve weeks post- and six months post-surgery)
|
|
Alcohol consume
Time Frame: 6 months after tibia surgery
|
Compensation cigarette abstinence with alcohol
|
6 months after tibia surgery
|
Questionnaire on Smoking Urges (QSU-G) - Score
Time Frame: 6 months after tibia surgery
|
6 months after tibia surgery
|
|
Smoking behaviour
Time Frame: 6 months after tibia surgery
|
Number of cigarettes or THS heets consume
|
6 months after tibia surgery
|
Nicotine withdrawal syndrome assessment - Checklist
Time Frame: 6 months after tibia surgery
|
6 months after tibia surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Aspera-Werz RH, Ehnert S, Muller M, Zhu S, Chen T, Weng W, Jacoby J, Nussler AK. Assessment of tobacco heating system 2.4 on osteogenic differentiation of mesenchymal stem cells and primary human osteoblasts compared to conventional cigarettes. World J Stem Cells. 2020 Aug 26;12(8):841-856. doi: 10.4252/wjsc.v12.i8.841.
- Weng W, Bovard D, Zanetti F, Ehnert S, Braun B, Uynuk-Ool T, Histing T, Hoeng J, Nussler AK, Aspera-Werz RH. Tobacco heating system has less impact on bone metabolism than cigarette smoke. Food Chem Toxicol. 2023 Mar;173:113637. doi: 10.1016/j.fct.2023.113637. Epub 2023 Jan 25.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 2, 2023
Primary Completion (Estimated)
October 15, 2025
Study Completion (Estimated)
April 17, 2026
Study Registration Dates
First Submitted
March 30, 2023
First Submitted That Met QC Criteria
May 4, 2023
First Posted (Actual)
May 16, 2023
Study Record Updates
Last Update Posted (Actual)
November 29, 2023
Last Update Submitted That Met QC Criteria
November 28, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IIS.SWI-THS.2022
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All IPD (in an anonymous form) that underlie results in a publication
IPD Sharing Time Frame
6 months after results are published in peer-reviewed international journal
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Smoking
-
University of Southern CaliforniaAmerican Cancer Society, Inc.CompletedSmoking | Smoking Cessation | Smoking, Cigarette | Smoking Behaviors | Cessation, SmokingUnited States
-
University of VirginiaRecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking, Cigarette | Quitting SmokingUnited States
-
Columbia UniversityNational Cancer Institute (NCI)RecruitingSmoking | Smoking Cessation | Smoking Reduction | Smoking BehaviorsUnited States
-
National Cancer Institute (NCI)CompletedSmoking | Smoking Cessation | Cigarette Smoking | Tobacco, SmokingUnited States
-
University GhentRecruitingSmoking | Smoking Tobacco | Smoking Prevention | Smoking CigaretteBelgium
-
Medical University of South CarolinaCompletedSmoking | Smoking Cessation | Smoking, Tobacco | Smoking, CigaretteUnited States
-
Maastricht University Medical CenterThe Investigative Desk; SEO Amsterdam Economics; IVO Research InstituteEnrolling by invitationSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsNetherlands
-
Jennifer Marler, MDCompletedSmoking Cessation | Smoking Reduction | Smoking, Tobacco | Smoking BehaviorsUnited States
-
Medical University of South CarolinaRecruitingSmoking | Smoking Cessation | Tobacco Smoking | Cigarette SmokingUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); University of Massachusetts, WorcesterRecruiting
Clinical Trials on Tobacco Heating System (THS)
-
Philip Morris Products S.A.Completed
-
Philip Morris Products S.A.Completed
-
Philip Morris Products S.A.WithdrawnCardiovascular Diseases | Coronary Artery Disease | Smoking | Peripheral Arterial Disease | Tobacco Use
-
Philip Morris Products S.A.RecruitingSmoking | Tobacco Use | COPDUnited States, Bulgaria, Czechia, Germany, Japan, Romania, Slovakia, United Kingdom
-
Philip Morris Products S.A.CompletedSmoking | Tobacco Use | Tobacco SmokingUnited Kingdom
-
University of RijekaCroatian Science FoundationCompleted
-
R.J. Reynolds Tobacco CompanyUniversity of Louisville; Covance; Analytisch-biologisches Forschungslabor GmbH; Arista Laboratories and other collaboratorsCompletedCigarette SmokingUnited States
-
Tata Memorial HospitalUnknownTobacco Use Cessation | ComplianceIndia
-
Öğr. Gör. Ali GÜZELHasan Kalyoncu UniversityRecruitingAbdominal Surgery | General Anesthesia | General SurgeryTurkey
-
University of TennesseeNational Heart, Lung, and Blood Institute (NHLBI); University of Minnesota; United...UnknownSmoking | Smoking CessationUnited States